Navina, a developer of AI-powered clinical platform for primary care, has secured $15 million in Series A funding led by Vertex Ventures Israel, the company announced Monday. Schusterman Family Investments (SFI) and existing investor Grove Ventures also joined the round. This brings the company's total funding to date to $22 million, raised within 12 months after commercial launch. The additional funding will allow Navina to accelerate investment in its AI technology, and expand within physician groups and the enterprise healthcare market.
Follow Israel Hayom on Facebook and Twitter
Navina created the first AI-based model that understands the complex language of primary care patient data. The platform provides clinicians with precise data as well as offering recommendations. Navina's AI-based insights bring potentially missed diagnoses to the attention of physicians, highlighting opportunities for better, more preventive patient care.
The company has been invited by the American Academy of Family Physicians to be part of its Innovation Lab.
Navina has also proven itself to increase practice revenue. Groups that have adopted the platform are seeing significant increases in HCC-RAF (Risk Adjustment Factor) scores, which translates into millions of dollars in revenue.
"We started Navina to help physicians make the most of all the digital data that is overwhelming them," said Ronen Lavi, co-founder and CEO. "Navina delivers deep patient understanding in a quick view, and will become core to every physician-patient interaction. We are honored that Vertex, Schusterman Family Investments, and Grove Ventures – who have been with us since the beginning – are committed to our vision of a new era of AI-powered care."
